1. Home
  2. EXAS vs YPF Comparison

EXAS vs YPF Comparison

Compare EXAS & YPF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EXAS
  • YPF
  • Stock Information
  • Founded
  • EXAS 1995
  • YPF 1977
  • Country
  • EXAS United States
  • YPF Argentina
  • Employees
  • EXAS N/A
  • YPF N/A
  • Industry
  • EXAS Medical Specialities
  • YPF Integrated oil Companies
  • Sector
  • EXAS Health Care
  • YPF Energy
  • Exchange
  • EXAS Nasdaq
  • YPF Nasdaq
  • Market Cap
  • EXAS 10.6B
  • YPF 10.8B
  • IPO Year
  • EXAS N/A
  • YPF 1993
  • Fundamental
  • Price
  • EXAS $57.01
  • YPF $24.16
  • Analyst Decision
  • EXAS Strong Buy
  • YPF Buy
  • Analyst Count
  • EXAS 21
  • YPF 5
  • Target Price
  • EXAS $67.86
  • YPF $46.70
  • AVG Volume (30 Days)
  • EXAS 2.3M
  • YPF 3.6M
  • Earning Date
  • EXAS 11-04-2025
  • YPF 11-07-2025
  • Dividend Yield
  • EXAS N/A
  • YPF N/A
  • EPS Growth
  • EXAS N/A
  • YPF N/A
  • EPS
  • EXAS N/A
  • YPF 2.41
  • Revenue
  • EXAS $2,939,949,000.00
  • YPF $16,939,451,352.00
  • Revenue This Year
  • EXAS $16.68
  • YPF $37.37
  • Revenue Next Year
  • EXAS $12.08
  • YPF N/A
  • P/E Ratio
  • EXAS N/A
  • YPF $10.75
  • Revenue Growth
  • EXAS 12.55
  • YPF 73.73
  • 52 Week Low
  • EXAS $38.81
  • YPF $21.40
  • 52 Week High
  • EXAS $72.83
  • YPF $47.43
  • Technical
  • Relative Strength Index (RSI)
  • EXAS 68.53
  • YPF 37.39
  • Support Level
  • EXAS $52.85
  • YPF $23.02
  • Resistance Level
  • EXAS $54.74
  • YPF $24.39
  • Average True Range (ATR)
  • EXAS 1.40
  • YPF 1.42
  • MACD
  • EXAS 0.17
  • YPF -0.07
  • Stochastic Oscillator
  • EXAS 93.39
  • YPF 19.97

About EXAS Exact Sciences Corporation

Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It also has a pipeline of blood-based tests for molecular residual disease, colorectal cancer screening, and multicancer screening.

About YPF YPF Sociedad Anonima

YPF SA is an Argentina-based integrated oil and gas company. It is engaged in operating a fully integrated oil and gas chain across the domestic upstream, downstream, and gas and power segments. Its upstream segment consists of exploration, development, and production of crude oil, natural gas, and LPG. Its downstream segment include refining, marketing, transportation, and distribution of oil and a wide range of petroleum products, petroleum derivatives, petrochemicals, LPG and bio-fuels. Gas and Power segment performs activities related to natural gas transportation to third parties and Downstream segment. Central Administration and Others includes activities performed by the Group not falling under the business segments. It generates maximum revenue from downstream segment.

Share on Social Networks: